Levitra 20 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

levitra 20 mg

orifarm as - vardenafilhydroklorid - tablett, filmdrasjert - 20 mg

Adempas Ευρωπαϊκή Ένωση - Νορβηγικά - EMA (European Medicines Agency)

adempas

bayer ag - riociguat - hypertensjon, pulmonal - antihypertensive midler for pulmonal arteriell hypertensjon - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. effekten har vært vist i en pah befolkningen, herunder aetiologies av idiopatisk eller heritable pah eller pah assosiert med bindevev sykdom. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

Rectogesic 4 mg/ g Νορβηγία - Νορβηγικά - Statens legemiddelverk

rectogesic 4 mg/ g

kyowa kirin holdings b.v. - glyseryltrinitrat - rektalsalve - 4 mg/ g

Nipruss 60 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

nipruss 60 mg

oresund pharma aps - natriumnitroprussiddihydrat - pulver til infusjonsvæske, oppløsning - 60 mg

Ismo Retard 40 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

ismo retard 40 mg

esteve pharmaceuticals gmbh - isosorbidmononitrat - depottablett - 40 mg

Ismo 20 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

ismo 20 mg

esteve pharmaceuticals gmbh - isosorbidmononitrat - tablett - 20 mg

Incivo Ευρωπαϊκή Ένωση - Νορβηγικά - EMA (European Medicines Agency)

incivo

janssen-cilag international n.v. - telaprevir - hepatitt c, kronisk - antivirale midler til systemisk bruk - incivo, i kombinasjon med peginterferon alfa og ribavirin, er indisert for behandling av genotype-1, kronisk hepatitt c hos voksne pasienter med kompensert leversykdom (inkludert skrumplever):hvem er behandling naiv, som tidligere har vært behandlet med interferon alfa (pegylated eller ikke-pegylated) alene eller i kombinasjon med ribavirin, inkludert relapsers, delvise besvarelser og null-respondere.